novel summary statistics are used to conclude that the doxorubicin screen covers a
dose-response data from the nci <dig> drug screen were used to illustrate the
dependency on drug exposure time and growth kinetics.
resampling based method for assessing variation of the novel summary statistics.
exploitation of data and biased conclusions on the potential of the drug in
estimates of the time independent summary statistics.
time independent summary statistics may aid the understanding of drugs’
in vitro generated dose-response curves of human cancer cell lines are
experiments depend on time so that fast growing cell lines compared to slowly
model is tested for doxorubicin and found to fit real data to an acceptable
isotonic regression for modelling the suggested dose-response curves, and 3)
dose response experimentsnci60doxorubicinmathematical modellingdifferential equation modellingnonlinear regressionisotonic regressionbootstrapparametric bootstrap
mathematical model the suggested statistical workflow results in unbiased
first, a mathematical model for drug induced cell growth inhibition was formulated
and used to derive novel dose-response curves and improved summary statistics that
we document that conventionally used summary statistics for dose-response
eliminating the impact of time dependency.
time dependency and demonstrate an adjustment correcting for it.
nonlinear regression models for estimation of cell counts and doubling times, 2)
statistics that ignore the conventionally used dose-response curves’
